Methamphetamine induces a low dopamine transporter expressing state without altering the total number of peripheral immune cells
Basic & Clinical Pharmacology & Toxicology · 2023
DOI: 10.1111/bcpt.13838 ↗Kurz gefasst
Fachartikel in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, 2023. Verfasst von Adithya Gopinath und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, University of Florida College of Medicine, Gainesville, Florida, USA. Hauptthemen laut MEDLINE: Methamphetamine, Central Nervous System Stimulants. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NCATS NIH HHS, NIDA NIH HHS.
Abstract (Originalsprache)
Methamphetamine is a widely abused psychostimulant and one of the main targets of dopamine transporter (DAT). Methamphetamine reduces DAT‐mediated dopamine uptake and stimulates dopamine efflux leading to increased synaptic dopamine levels many folds above baseline. Methamphetamine also targets DAT‐expressing peripheral immune cells, reduces wound healing and increases infection susceptibility. Peripheral immune cells such as myeloid cells, B cells and T cells express DAT. DAT activity on monocytes and macrophages exhibits immune suppressive properties via an autocrine paracrine mechanism, where deletion or inhibition of DAT activity increases inflammatory responses. In this study, utilizing a mouse model of daily single dose of methamphetamine administration, we investigated the impact of the drug on DAT expression in peripheral immune cells. We found in methamphetamine‐treated mice that DAT expression was down‐regulated in most of the innate and adaptive immune cells. Methamphetamine did not increase or decrease the total number of innate and adaptive immune cells but changed their immunophenotype to low‐DAT‐expressing phenotype. Moreover, serum cytokine distributions were altered in methamphetamine‐treated mice. Therefore, resembling its effect in the CNS, in the periphery, methamphetamine regulates DAT expression on peripheral immune cell subsets, potentially describing methamphetamine regulation of peripheral immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuroscience, University of Florida College of Medicine, Gainesville, Florida, USA.
- Department of Oral Biology, University of Florida College of Dentistry, Gainesville, Florida, USA.
- Emerging Pathogens Institute, University of Florida, Gainesville, Florida, USA.
- Center for Immunology and Transplantation, University of Florida, Gainesville, Florida, USA.
- Center for Translational Research in Neurodegenerative Disease, University of Florida, Gainesville, Florida, USA.
ORCID-Profile: Adithya Gopinath
Förderung
- NINDS NIH HHS
- NCATS NIH HHS
- NIDA NIH HHS
- NIAID NIH HHS
- National Center for Advancing Translational Sciences
- National Institute of Neurological Disorders and Stroke
- National Institute on Drug Abuse
- Karen Toffler Charitable Trust
Zitieren
APA
Gopinath, A., Riaz, T., Miller, E., Phan, L., Smith, A., Syed, O., Franks, S., Martinez, L. R., & Khoshbouei, H. (2023). Methamphetamine induces a low dopamine transporter expressing state without altering the total number of peripheral immune cells. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.13838
Vancouver
Gopinath A, Riaz T, Miller E, Phan L, Smith A, Syed O, et al. Methamphetamine induces a low dopamine transporter expressing state without altering the total number of peripheral immune cells. Basic & Clinical Pharmacology & Toxicology. 2023. doi:10.1111/bcpt.13838
BibTeX
@article{Gopinath2023,
author = {Gopinath, Adithya and Riaz, Tabish and Miller, Emily and Phan, Leah and Smith, Aidan and Syed, Ohee and Franks, Stephen and Martinez, Luis R and Khoshbouei, Habibeh},
title = {Methamphetamine induces a low dopamine transporter expressing state without altering the total number of peripheral immune cells},
journal = {Basic & Clinical Pharmacology & Toxicology},
year = {2023},
doi = {10.1111/bcpt.13838}
}
EUVIMED